Bococizumab (Anti-PCSK9)
Bococizumab (Anti-PCSK9) (A2788-GRP)
Products
Description
Bococizumab (Anti-PCSK9) is a humanized monoclonal IgG2Δa antibody against proprotein convertase subtilisin/kexin type 9 (PCSK9) used for the treatment of hyperlipidemia. MW: 145.06 kD.
Specifications
| Manufacturer | Selleck Chemicals LLC |
|---|---|
| Manufacturer Cat# | A2788 |
| Target | PCSK9 |